Literature DB >> 8720613

Population-based genetic screening for IDDM susceptibility as a source of HLA-genotyped control subjects.

J Ilonen, H Reijonen, M Knip, O Simell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8720613     DOI: 10.1007/BF00400423

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  4 in total

1.  HLA-matched control subjects are essential in studies of susceptibility to IDDM.

Authors:  N Petrovsky; L C Harrison
Journal:  Diabetologia       Date:  1995-01       Impact factor: 10.122

2.  The selection of control subjects for case/control analysis of susceptibility to type 1 (insulin-dependent) diabetes mellitus.

Authors:  P Pozzilli; R Buzzetti; G F Bottazzo; R Tosi
Journal:  Diabetologia       Date:  1993-11       Impact factor: 10.122

3.  Triple-label hybridization assay for type-1 diabetes-related HLA alleles.

Authors:  M Sjöroos; A Iitiä; J Ilonen; H Reijonen; T Lövgren
Journal:  Biotechniques       Date:  1995-05       Impact factor: 1.993

4.  HLA-DQB1 alleles and absence of Asp 57 as susceptibility factors of IDDM in Finland.

Authors:  H Reijonen; J Ilonen; M Knip; H K Akerblom
Journal:  Diabetes       Date:  1991-12       Impact factor: 9.461

  4 in total
  3 in total

Review 1.  Genetic predisposition to IDDM.

Authors:  S Caillat-Zucman; J F Bach
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

Review 2.  Metabolomic Biomarkers in the Progression to Type 1 Diabetes.

Authors:  Anne Julie Overgaard; Simranjeet Kaur; Flemming Pociot
Journal:  Curr Diab Rep       Date:  2016-12       Impact factor: 4.810

3.  The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants.

Authors:  William A Hagopian; Henry Erlich; Ake Lernmark; Marian Rewers; Anette G Ziegler; Olli Simell; Beena Akolkar; Robert Vogt; Alan Blair; Jorma Ilonen; Jeffrey Krischer; JinXiong She
Journal:  Pediatr Diabetes       Date:  2011-05-12       Impact factor: 3.409

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.